1. Catalogs
  2. GE Healthcare
  3. Invenia™ABUS

Invenia™ABUS

Invenia™ABUS

Invenia™ABUS

Product catalog summary
Introduction
The document discusses the Invenia™ ABUS (Automated Breast Ultrasound) by GE Healthcare, highlighting its importance in detecting breast cancer, especially in women with dense breast tissue. Dense breast tissue can mask tumors, making mammography less effective.

Problem Statement
Dense breast tissue increases the risk of developing cancer by four to six times. Over 40% of women have dense breast tissue, which can obscure tumors and reduce mammography effectiveness, missing over one-third of cancers.

Enhanced Detection and Diagnosis
The Invenia ABUS system enhances cancer detection, showing a 55% relative increase in identifying invasive breast cancers in dense tissue and a 37% overall increase compared to mammography alone. Clinical studies confirm its accuracy and cost-effectiveness in staging breast cancers before surgery.

Technological Features
The Invenia ABUS features advanced imaging algorithms and a powerful imaging architecture that shifts from hardware to software-based processing. This results in high-resolution images with uniformity. The system includes a user-friendly touchscreen and intelligent imaging algorithms for consistent image quality.

Design and Workflow
The Reverse Curve™ transducer enhances patient comfort and breast coverage, providing uniform compression for consistent image quality. The Invenia ABUS Workstation displays 3D volumes efficiently, allowing quick exam reading and analysis within three minutes.

Support and Training
GE Healthcare offers customizable marketing tools and comprehensive education through the Invenia ABUS Mastery Program, providing training for physicians and technicians.

Conclusion
The Invenia ABUS system is a significant advancement in breast cancer screening, particularly for women with dense breast tissue, offering enhanced detection, diagnosis, and workflow efficiency.
See more

Catalog excerpts

Invenia™ABUS-1

Look differently. Invenia ABUS ™  Automated Breast Ultrasoun

 Open the catalog to page 1
Invenia™ABUS-2

The unseen risk. Too many tumors are missed. Having dense breasts increases a women‘s likelihood to develop cancer four to six times. 1 This is a significant problem. Over 40% of women have dense breast tissue, ² which can mask the appearance of tumors and limit the performance of mammography. Mammography may miss over 1/3 of cancers in dense breasts. ³ When it is warranted to look beyond mammography, there now is a screening technology that can effectively detect cancer to help deliver confidence and peace of mind. For a woman with dense breasts, screening with mammography may not be

 Open the catalog to page 2
Invenia™ABUS-3

Enhanced Detection. Invenia ABUS contribute to find more cancers.4 Enhanced Diagnosis. Global View for planning. Screening with ABUS has a 55% relative increase in invasive breast cancers identified in dense breast tissue using supplemental ABUS and a 37% relative increase in cancer detection overall than mammography alone. ⁴ 93% were INVASIVE Breast Cancer 93% were NODE NEGATIVE DCIS Invasive Node Positive Node Negative Multiple clinical research studies demonstrate that physicians can detect more cancers at an earlier, more treatable stage. 4 Clinical studies confirmed the accurate, costeffective...

 Open the catalog to page 3
Invenia™ABUS-4

Designed for automated screening. Remarkable Architecture. Advanced imaging algorithms. Powerful Imaging Architecture User-friendly touchscreen Invenia ABUS’s imaging architecture shifts traditional ultrasound from hardware- to software-based processing, resulting in exceptional performance for the fast paced breast imaging environment. With its massive parallel processing power and proprietary beamforming technology, the system creates focus at every pixel, delivering an image of high uniformity and resolution Operator workflow is smooth and easy with the Invenia ABUS high-resolution touchscreen...

 Open the catalog to page 4
Invenia™ABUS-5

Shaped for a woman‘s anatomy. The Reverse CurveTM transducer Contribute to enhance both patient comfort and breast coverage during the exam. The 15 cm wide field-of-view high-frequency transducer automatically creates uniform compression across the entire breast for consistent, reproducible image quality independent of the operator. The convergent scan line geometry allow to minimize beam refraction.   Enhanced anatomical detail   Deep penetration A fast, efficent workflow. Invenia ABUS Workstation The Invenia ABUS Workstation displays 3D volumes in a patented, 2 mm thick coronal slice from the...

 Open the catalog to page 5
Invenia™ABUS-6

Support beyond technology. Customizable marketing tools Targeted marketing tools feature clinically researched and professionally designed content to help you promote Invenia ABUS screening to referring physicians, their patients, and women. Comprehensive education and training The Invenia ABUS Mastery Program for physicians and technicians uses progressive teaching techniques led by our experienced team of peer educators and clinical applications specialists. GE Healthcare GmbH Beethovenstr. 239 42655 Solingen, Germany T +49 212-28 02-0 F +49 212-28 02-28 www.gehealthcare.com UNITED KINGDOM...

 Open the catalog to page 6
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.